VOX vs XBI
Vanguard Communication Services ETF vs SPDR S&P Biotech ETF
- • VOX has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VOX pays a higher dividend yield (1.07%).
Side-by-side metrics
| Metric | VOX | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.07% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $5.93B | $10.73B |
YTD return | -2.72% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 1.10 |
P/E ratio | 17.02 | — |
Last price | $189.59 | $164.28 |
Inception | — | — |
Issuer | Vanguard | State Street |
VOX top holdings
| META | Meta Platforms Inc Class A | 22.12% |
| GOOGL | Alphabet Inc Class A | 14.10% |
| GOOG | Alphabet Inc Class C | 7.51% |
| VZ | Verizon Communications Inc | 4.42% |
| DIS | The Walt Disney Co | 4.39% |
| T | AT&T Inc | 4.38% |
| NFLX | Netflix Inc | 4.25% |
| CMCSA | Comcast Corp Class A | 3.82% |
| TMUS | T-Mobile US Inc | 3.78% |
| WBD | Warner Bros. Discovery Inc Ordinary Shares - Class A | 3.44% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VOX
VOX (Vanguard Communication Services ETF) is US communication services sector stocks. Managed by Vanguard, the fund carries $5.9B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.07%. Its largest holding is Meta Platforms Inc Class A (META), which represents 22.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.